SGMO - Sangamo Therapeutics, Inc. Net Sales Margin

Sangamo Therapeutics, Inc. - graphic logo of issuer SGMO

Sangamo Therapeutics ensures business resilience through the diversification of rare biomaterial supplies. A balanced net margin demonstrates the efficiency of operational processes, where the value -310.80 represents the current metric. Revenues are based on partnerships for the treatment of genetic pathologies; however, limited cash reserves and a revision of the clinical research strategy create serious risks to the company's stability.

Sangamo BioSciences (SGMO) Net Profit Margin: for the period 07/04/2022 - 05/09/2026

SGMO (Sangamo Therapeutics): analytical breakdowns and indicator data

- market value and analyst target forecast:
- cash availability and cash flow indicators:
Fundamental company valuation:Sangamo Therapeutics Inc. - SGMO
Finished products of Sangamo BioSciences

Conservative investors must track the net profit margin per dollar of revenue, as the basic net sales margin objectively captures cost management efficiency and final profitability. For Sangamo Therapeutics (SGMO), this indicator will serve as key confirmation of the monetization of zinc finger patents once technological dominance in gene therapy enables the company to establish premium pricing power and reverse the long-term profitability trend.

Competitors of Sangamo Therapeutics (SGMO)

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX